This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Mendi A Morton: Innovator in Anorexiant Agents
Introduction
Mendi A Morton is a notable inventor based in Middletown, CT (US). She has made significant contributions to the field of pharmacology, particularly in the development of compounds that target neuropeptide Y (NPY) receptors. Her work focuses on creating effective treatments for weight loss and eating disorders.
Latest Patents
Mendi A Morton holds a patent for "Dihydropyridine NPY antagonists: cyanoguanidine derivatives." This patent describes a series of non-peptidergic antagonists of NPY, synthesized from cyanoguanidine derivatives of 4-phenyl-1,4-dihydropyridines. These compounds are designed to act as antagonists of NPY-induced feeding behavior, with the potential to serve as effective anorexiant agents.
Career Highlights
Mendi A Morton is associated with Bristol-Myers Squibb Company, where she applies her expertise in drug development. Her innovative approach has led to advancements in the treatment of obesity and related disorders.
Collaborations
Mendi has collaborated with esteemed colleagues such as Graham S Poindexter and R Thomas Swann. Their combined efforts contribute to the ongoing research and development of new therapeutic agents.
Conclusion
Mendi A Morton is a pioneering inventor whose work in developing NPY antagonists showcases her commitment to addressing critical health issues. Her contributions to pharmacology are paving the way for new treatments in weight management and eating disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile